GMABNasdaqPharmaceutical PreparationsAlso trades as GNMSF
GENMAB A/S
Financials through fiscal 2025, year ended Dec 31, 2025
$38.50+1.50 (+4.05%)
Close on Oct 19, 2026
Share price
+$5.33 (+16.07%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Diluted shares
- 63M
Valuation needs the share price. It fills in once daily prices are connected and converted from DKK.
Ten years at a glance
Fiscal years 2016 to 2025, DKK
Revenue
–
Gross profit
–
Operating income
–
EPS, diluted
–
Free cash flow
–
Reported period